Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-791-1 | CAS number: 870-08-6
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- Not reported
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: The data was only available as a short abstract as part of a MSDS, it is not possible to assess the accuracy of the data from the information presented.
Data source
Reference
- Reference Type:
- other company data
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 2000
Materials and methods
- Principles of method if other than guideline:
- Information on methods not reported, data presented as a short abstract only.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Dioctyltin oxide
- EC Number:
- 212-791-1
- EC Name:
- Dioctyltin oxide
- Cas Number:
- 870-08-6
- Molecular formula:
- C16H34OSn
- IUPAC Name:
- dioctylstannanone
- Test material form:
- not specified
- Details on test material:
- - Name of test material (as cited in study report): Dioctyltin oxide
Constituent 1
Test animals
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
Administration / exposure
- Route of administration:
- oral: unspecified
- Vehicle:
- not specified
- Control animals:
- not specified
Results and discussion
Effect levels
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 4 000 mg/kg bw
- Based on:
- not specified
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral LD50 of the test substance was reported to be greater than 4000 mg/kg bw.
- Executive summary:
Information pertaining to the methods used to generate the data was not reported, the data was presented as a short abstract only. The acute oral LD50 of the test substance was reported to be greater than 4000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
